Outcomes with different administration schedules of bortezomib in bortezomib, lenalidomide and dexamethasone (VRd) as first-line therapy in multiple myeloma

Joselle Cook, Isla Johnson, Alexandra Higgins, Surbhi Sidana, Rahma Warsame, Wilson Gonsalves, Morie A. Gertz, Francis Buadi, Martha Lacy, Prashant Kapoor, Angela Dispenzieri, Taxiarchis Kourelis, David Dingli, Amie Fonder, Suzanne Hayman, Miriam Hobbs, Yi Lisa Hwa, Robert Kyle, Nelson Leung, Ronald GoVincent S. Rajkumar, Shaji Kumar

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Outcomes with different administration schedules of bortezomib in bortezomib, lenalidomide and dexamethasone (VRd) as first-line therapy in multiple myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences